1298. Population Pharmacokinetics of Ceftazidime-avibactam among Critically-ill Patients with and without Receipt of Continuous Renal Replacement Therapy

BACKGROUND: Ceftazidime-avibactam (CAZ-AVI) is used to treat multidrug-resistant infections. There are limited pharmacokinetic (PK) data among critically-ill patients (pts) and no dosing recommendations for those receiving continuous renal replacement therapy (CRRT). METHODS: We conducted a PK study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kline, Ellen G, Nguyen, Minh Hong T, McCreary, Erin K, Wildfeuer, Brett, Kohl, Josh, Hughes, Kailey L, Jones, Chelsea E, Doi, Yohei, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776588/
http://dx.doi.org/10.1093/ofid/ofaa439.1481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776588/
http://dx.doi.org/10.1093/ofid/ofaa439.1481

Ejemplares similares